Head and neck squamous cell carcinomas (HNSCCs) are an aggressive, genetically
complex and difficult to treat group of cancers. In lieu of truly effective targeted therapies …

Head and neck squamous cell carcinomas (HNSCCs) are the sixth most common cancers
worldwide. More than half of patients with HNSCC eventually experience disease …

In heterogeneous head and neck cancer (HNC), subtype-specific treatment regimens are
currently missing. An integrated analysis of patient HNC subtypes using single-cell …

Head and neck squamous cell carcinoma (HNSCC) is the sixth most incident cancer
worldwide. More than half of HNSCC patients experience locoregional or distant relapse to …

The mechanism and gene markers of head and neck squamous cell carcinoma (HNSCC), a
common malignant tumor, have not yet been identified. The aim of this study was to identify …

Immune evasion is a hallmark feature of cancer, and it plays an important role in tumour
initiation and progression. In addition, tumour immune evasion severely hampers the …

Head and neck squamous cell carcinoma (HNSCC) is considered as an
immunosuppressive disease, with impaired tumor-infiltrating T lymphocytes and increased …

There is an unmet need for effective targeted therapies for patients with advanced head and
neck squamous cell carcinoma (HNSCC). We correlated gene expression, gene copy …

Head and neck squamous cell carcinomas (HNSCCs) are one of the most common cancers
worldwide. A large number of patients are diagnosed with locally advanced disease and …

The substantial heterogeneity exhibited by head and neck cancer (HNC), encompassing
diverse cellular origins, anatomical locations, and etiological contributors, combined with the …